PNH and Thrombosis - Aplastic Anemia & MDS International ...
PNH and Thrombosis - Aplastic Anemia & MDS International ...
PNH and Thrombosis - Aplastic Anemia & MDS International ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
TPA for <strong>Thrombosis</strong> in <strong>PNH</strong><br />
McMullin, M F. Hillmen, P. Jackson, J. Ganly, P. Luzzatto, L.<br />
Tissue plasminogen activator for hepatic vein thrombosis in <strong>PNH</strong><br />
Journal of Internal Medicine. 235(1):85-9, 1994 Jan.<br />
ABSTRACT:<br />
Paroxysmal nocturnal haemoglobinuria (<strong>PNH</strong>) is an acquired clonal disorder thought<br />
to arise in a multipotent haemopoietic stem cell. A distinct clinical feature is a<br />
tendency to thrombosis, with a particular predilection for the hepatic veins (Budd-<br />
Chiari syndrome). We report here on two patients with <strong>PNH</strong> who developed hepatic<br />
vein thrombosis (HVT) <strong>and</strong> who were treated with tissue plasminogen activator (t-PA).<br />
Both patients had a marked clinical <strong>and</strong> radiological improvement following the t-PA<br />
treatment <strong>and</strong> remain well over 2 years <strong>and</strong> 6 years after the treatment. This method<br />
of thrombolysis for HVT occurring in <strong>PNH</strong> has only been reported in two previous<br />
patients with limited follow-up. We suggest that this therapy is a useful first-line<br />
treatment for <strong>PNH</strong> patients who develop HVT.
Change language